Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
about
P1343
Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancerThe many faces of neuroendocrine differentiation in prostate cancer progressionRole of the TMPRSS2-ERG gene fusion in prostate cancerTMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer modelNeoplasia: the second decade.TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.Optical coding of fusion genes using multicolor quantum dots for prostate cancer diagnosis.Antibody-based detection of ERG rearrangement-positive prostate cancerMolecular pathways: targeting ETS gene fusions in cancer.Organoid cultures derived from patients with advanced prostate cancer.Genome Fusion Detection: a novel method to detect fusion genes from SNP-array data.5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancerEstrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivityIn vitro and in vivo model systems used in prostate cancer research.Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges.Fusion transcript loci share many genomic features with non-fusion loci.Dual roles of PARP-1 promote cancer growth and progression.Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.Molecular pathogenesis and progression of prostate cancerThe discovery and application of gene fusions in prostate cancer.Distinct genomic aberrations associated with ERG rearranged prostate cancerRecurrent gene fusions in prostate cancerTranslocations in epithelial cancers.Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma.The War on Cancer rages on.GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer ProgressionERG expression in prostate cancer: biological relevance and clinical implication.FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation.Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.Gene fusions by chromothripsis of chromosome 5q in the VCaP prostate cancer cell line.Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts.PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy.
P2860
Q24649955-38391AA9-0CC2-401D-A91D-C3D9CA2EAC64Q26992049-60D57FFE-DC71-4F13-B27B-E6FE7824DDFAQ28269156-865B6F08-2CFF-47A3-8F27-C6BDA17F8211Q28478908-BDB8F6CA-D2CD-4315-9C56-4513D64799C2Q30484000-E231CF01-B82B-4D7B-B636-0131F8810BDCQ31042968-C6F46772-55E0-48E5-8031-4222A3C43C19Q33648775-24EE2B48-379D-49BB-82F2-F7C5764A1CACQ33772417-3A901FA7-2159-4FEA-B73B-BB9A973BB7DCQ33812744-36963982-DB39-4CF6-B6CF-38B74CDB6D18Q34009867-A3D5C58C-C5CE-4EC0-A3F1-A3D0630DE44DQ34135434-02EE898D-E6D5-4B67-85FF-F70D1C3945B1Q34545103-B67371F1-7049-485F-9CD8-318FFECAEFCBQ34557870-E3EC4693-8412-4694-8B28-E769DAAD7B6FQ34614232-3010265C-6367-46E2-8203-FEFE6FEE53C5Q34775924-C7C936FB-D9AF-4C47-947E-3F07ADFFC405Q35176093-F6A62F08-7C56-42E0-82BF-503DB8F6508AQ35806390-3BD7D0D9-4E7E-4BDD-8BC9-789111CEBE50Q35838821-2EA0A001-F299-484C-9C9E-7E478689A7ECQ35857757-7719D8BE-C657-4880-A634-6714382711ABQ36460391-39FB937F-793C-4CCB-8FC1-AA88504350F2Q36860976-E5419A49-ABAF-4661-A519-F6ADC4066A8FQ37055715-257A4245-E55F-492D-B02E-8897872F39C9Q37142194-702A5A00-6E7B-47CA-8113-1B492F0DC4BCQ37173727-04057C35-5697-4CEA-B2BA-B6EB41AB10D6Q37194503-EC42E5B4-F3DC-4F58-AF49-5738909C633EQ37363960-93C88594-C40F-4D40-A5F6-EFC6D2839C94Q37383449-03DAD714-AD1E-457A-B10B-2AAE0BF225BFQ37478602-BE0DD309-3394-47EC-8066-7F3286BE5D94Q37564369-E85AF684-1C47-49E9-868F-B934AF3B798CQ38069582-188499F7-FA38-4498-8506-C70B5492C5E0Q38681610-4C63396C-E033-4739-B44B-468E51E38DBFQ38722718-0A53B5FF-F1C8-447F-A04A-2847F8EB9038Q38723072-56D226A4-8471-4290-85BF-FC79D2A0C937Q38723089-BB645A74-95E0-4B99-AEB5-21140929F9DEQ38943216-A3186B6D-9712-4892-8611-E2464551435BQ38952586-A8C5D21B-9F50-4EC3-A95D-C096F1C6FD7DQ39051416-FA3A8F39-07D7-4138-A034-A08D0243FFF9Q39160994-17A87ED5-37D0-434A-92E2-27A19B1BAEF9Q39205279-5DD5D4C2-8BF2-4E21-B20A-0974C592C1A2Q39437808-5EABAC3F-6324-442F-90F3-2819C06CDC3F
P2860
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Molecular characterization of ...... perspective for an old model.
@ast
Molecular characterization of ...... perspective for an old model.
@en
type
label
Molecular characterization of ...... perspective for an old model.
@ast
Molecular characterization of ...... perspective for an old model.
@en
prefLabel
Molecular characterization of ...... perspective for an old model.
@ast
Molecular characterization of ...... perspective for an old model.
@en
P2093
P2860
P50
P356
P1433
P1476
Molecular characterization of ...... w perspective for an old model
@en
P2093
Arul M Chinnaiyan
Bharathi Laxman
Charles Lee
Joëlle Tchinda
Kirsten D Mertz
Rameen Beroukhim
Robert L Vessella
Scott Tomlins
Sunita R Setlur
Sven Perner
P2860
P304
P356
10.1593/NEO.07103
P577
2007-03-01T00:00:00Z